Equitable Holdings, Inc. (EQH) Q2 2025 Earnings Call Transcript

Equitable Holdings reported Q2 2025 non-GAAP operating EPS of $1.41 (adjusted for notable items), an 8% year-over-year decline attributed primarily to elevated individual life mortality claims and lower equity markets. Despite this, the company achieved record $1.1 trillion in assets under management and administration and strong organic growth across wealth management and retirement. A key strategic move, the July close of the Individual Life reinsurance transaction with RGA, freed over $2 billion in capital, significantly reducing earnings volatility and enabling a $760 million increase in AllianceBernstein ownership and planned incremental share repurchases of at least $500 million in H2 2025. With a robust pro forma RBC over 500%, Equitable anticipates accelerated EPS growth in the second half and remains confident in achieving its 2027 financial targets.

Analysis

Equitable Holdings (EQH) reported a mixed second quarter, with adjusted non-GAAP operating EPS of $1.41 declining 8% year-over-year, primarily due to elevated mortality claims in its individual life segment and lower average equity markets. However, the headline earnings miss is overshadowed by a significant strategic de-risking. The closure of its landmark reinsurance transaction with RGA in July has reduced its mortality exposure by 75%, freeing over $2 billion in capital and fundamentally shifting the company's risk profile towards more predictable earnings streams. Management is actively redeploying this capital, having used $760 million to increase its AllianceBernstein (AB) stake to 69% and committing to at least $500 million in incremental share repurchases in the second half of 2025. Underlying business momentum remains strong in key growth areas, with Wealth Management delivering a 12% trailing twelve-month organic growth rate and the Retirement business producing $1.9 billion of net inflows. While the Individual Retirement segment faces near-term margin pressure from the runoff of higher-return legacy products, and AB saw modest outflows, the company's record $1.1 trillion in AUM, a strong pro forma RBC ratio over 500%, and the benefits from the reinsurance deal position it for accelerated EPS growth in the latter half of the year.

Key Decisions for Investors

• Investors should re-evaluate the company based on its new, de-risked profile, focusing on the more predictable earnings from retirement, wealth, and asset management now that the significant volatility from mortality risk has been reduced by 75% through the RGA transaction.
• Monitor the effectiveness of capital deployment, as the accretion from the $2 billion in freed capital hinges on the execution of the $500 million incremental share buyback, prudent debt repayment, and any potential bolt-on acquisitions.
• Consider the provided Q3 earnings baseline for the Individual Retirement segment ($220M-$225M) as a new starting point, and watch for evidence that strong organic growth can offset the margin compression from the runoff of legacy, high-return RILA products.
• Track progress toward the reaffirmed 12-15% annual EPS growth target, as management's credibility depends on demonstrating a clear acceleration in H2 2025, driven by reduced mortality drag and accretive buybacks.